Allianz US High Yield AM vs UBS Lux Equity Fund Biotech USD
1. Allianz US High Yield AM
2. UBS Lux Equity Fund Biotech USD
Fund Holdings
We have information about 5 holdings in Allianz US High Yield AM, where the largest holding is CCF Holdings (2.69), followed by CCO Holdings LLC (2.2) and Iron Mountain (2.05). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).
All Holdings
Here we compare the holdings in Allianz US High Yield AM and UBS Lux Equity Fund Biotech USD.
Allianz US High Yield AM |
UBS Lux Equity Fund Biotech USD |
1. CCF Holdings LLC  2.69 % |
1. Regeneron Pharmaceuticals Inc 10.04 % |
2. CCO Holdings LLC  2.2 % |
2. Vertex Pharmaceuticals Inc 9.35 % |
3. Iron Mountain Inc  2.05 % |
3. Moderna Inc 9.21 % |
4. Caesars Entertainment Inc 1.53 % |
4. Alnylam Pharmaceuticals Inc 6.96 % |
5. Bombardier Inc Pref 1.31 % |
5. AbbVie Inc  5.53 % |
- |
6. Gilead Sciences Inc  4.66 % |
- |
7. Amgen Inc 4.3 % |
- |
8. BioNTech SE 4.13 % |
- |
9. Karuna Therapeutics Inc 3.75 % |
- |
10. Royalty Pharma Plc 3.37 % |
The list of fund holdings was last updated on June 5, 2025.